Nuchal translucency and other first-trimester sonographic markers of chromosomal abnormalities

This publication has 198 references indexed in Scilit:

• Comparison of fetal nasal bone assessment by ultrasound at 11–14 weeks and by postmortem X‐ray in trisomy 21: a prospective observational study
  Ultrasound in Obstetrics & Gynecology, 2003
• Measurement of nasal bone length at 11–14 weeks of pregnancy and its potential role in Down syndrome risk assessment
  Ultrasound in Obstetrics & Gynecology, 2003
• A histological and radiological investigation of the nasal bone in fetuses with Down syndrome
  Ultrasound in Obstetrics & Gynecology, 2003
• The effect of image size on nuchal translucency measurement
  Prenatal Diagnosis, 2003
• Agreement between predicted risk and prevalence of Down syndrome in first trimester nuchal translucency screening
  Prenatal Diagnosis, 2002
• Association between first trimester absence of fetal nasal bone on ultrasound and Down syndrome
  Prenatal Diagnosis, 2002
• The first trimester ‘combined test’ for the detection of Down syndrome pregnancies in 4939 unselected pregnancies
  Prenatal Diagnosis, 2002
• Effect of fetal gender on first trimester markers and on Down syndrome screening
  Prenatal Diagnosis, 2001
• Absence of nasal bone in fetuses with trisomy 21 at 11–14 weeks of gestation: an observational study
  The Lancet, 2001
• Screening for trisomy 21 in twin pregnancies in the first trimester using free ?-hCG and PAPP-A, combined with fetal nuchal translucency thickness
  Prenatal Diagnosis, 2000